Table of Content

1 Industry Outlook
1.1 Industry Overview
1.2 Total Addressable Market
1.3 Industry Trends
2 Report Outline
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 Market Snapshot
3.1 Market Definition – Infoholic Research
3.2 Advantages of Point-of-Care Testing
3.3 Disadvantages of Point-of-Care Testing
3.4 Segmented Addressable Market
3.5 Trends in the Point-of-Care Diagnostics Market
3.6 Related Markets
3.6.1 Molecular Diagnostics
3.6.2 Infectious Disease Diagnostics
4 Market Outlook
4.1 Market Segmentation
4.2 PEST Analysis
4.3 Porter 5 (Five) Forces
5 Market Characteristics
5.1 DRO – Market Dynamics
5.1.1 Drivers
5.1.1.1 Increasing prevalence of infectious disease
5.1.1.2 Growing incidence of lifestyle disease
5.1.1.3 Technological innovations
5.1.1.4 Increasing adoption of point-of-care diagnostics
5.1.2 Opportunities
5.1.2.1 Growth opportunities in emerging markets
5.1.2.2 Increasing awareness towards point-of-care diagnostics in developing countries
5.1.3 Restraints
5.1.3.1 Stringent approval process
5.1.3.2 Product recalls
5.1.3.3 Unfavorable reimbursement scenario
5.2 DRO – Impact Analysis
5.3 Key Stakeholders
6 Product: Market Size and Analysis
6.1 Overview
6.2 Glucose Monitoring
6.3 Infectious Disease Testing
6.3.1 Influenza Testing
6.3.2 HIV Testing
6.3.3 Hepatitis Testing
6.3.4 Tuberculosis Testing
6.3.5 Sexually Transmitted Diseases Testing
6.3.6 Healthcare-associated Infections Testing
6.3.7 Respiratory Infections Testing
6.3.8 Others
6.4 Pregnancy and Fertility Testing
6.5 Hematology Testing
6.6 Cardiometabolic Monitoring
6.7 Urinalysis Testing
6.8 Coagulation Monitoring
6.9 Tumor or Cancer Marker Testing
6.10 Cholesterol Testing
6.11 Drugs of Abuse Testing
6.12 Others
7 Prescription Mode: Market Size and Analysis
7.1 Overview
7.2 Prescription-based Point-of-Care Diagnostics
7.3 Over the Counter-based Point-of-Care Diagnostics
8 End-users: Market Size and Analysis
8.1 Overview
8.2 Hospitals
8.3 Clinics/Physician Office Laboratory (POL)
8.4 Home Care
8.5 Ambulatory Care
8.6 Others
9 Regions: Market Size and Analysis
9.1 Overview
9.2 North America
9.2.1 Overview
9.2.2 US
9.2.3 Canada
9.3 Europe
9.3.1 Overview
9.3.2 UK
9.3.3 Germany
9.3.4 France
9.3.5 Spain
9.3.6 Italy
9.3.7 Others
9.4 APAC
9.4.1 Overview
9.4.2 India
9.4.3 China
9.5 Rest of the World
10 Competitive Landscape
10.1 Overview
11 Vendors Profile
11.1 Abbott Laboratories
11.1.1 Overview
11.1.2 Business Units
11.1.3 Geographic Revenue
11.1.4 Business Focus
11.1.5 SWOT Analysis
11.1.6 Business Strategies
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Overview
11.2.2 Business Units
11.2.3 Geographic Revenue
11.2.4 Business Focus
11.2.5 SWOT Analysis
11.2.6 Business Strategies
11.3 Johnson & Johnson
11.3.1 Overview
11.3.2 Business Units
11.3.3 Geographic Revenue
11.3.4 Business Focus
11.3.5 SWOT Analysis
11.3.6 Business Strategies
11.4 Danaher Corporation
11.4.1 Overview
11.4.2 Business Units
11.4.3 Geographic Revenue
11.4.4 Business Focus
11.4.5 SWOT Analysis
11.4.6 Business Strategies
11.5 Siemens Healthineers Inc. (Siemens AG)
11.5.1 Overview
11.5.2 Business Units
11.5.3 Geographic Revenue
11.5.4 Business Focus
11.5.5 SWOT Analysis
11.5.6 Business Strategies
12 Companies to Watch For
12.1 Trinity Biotech plc
12.1.1 Overview
12.2 Qiagen N.V.
12.2.1 Overview
12.3 BioMerieux S.A.
12.3.1 Overview
12.4 OraSure Technologies Inc.
12.4.1 Overview
12.5 Instrumentation Laboratory (A Werfen Company)
12.5.1 Overview
12.6 Becton Dickinson and Company
12.6.1 Overview
12.7 Nova Biomedical
12.7.1 Overview
Annexure
Abbreviations
 



List of Figures


Charts

CHART 1 RESEARCH METHODOLOGY OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 13
CHART 2 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE, 2019–2025 ($MILLION) 17
CHART 3 SEGMENTATION OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 21
CHART 4 PEST ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 21
CHART 5 PORTER 5 FORCES ON GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 23
CHART 6 DRO – IMPACT ANALYSIS OF GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET 29
CHART 7 KEY STAKEHOLDERS 31
CHART 8 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRODUCT, 2018 V/S 2025 ($) 32
CHART 9 GLOBAL GLUCOSE MONITORING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 34
CHART 10 GLOBAL INFECTIOUS DISEASE TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 35
CHART 11 GLOBAL INFLUENZA TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 37
CHART 12 GLOBAL HIV TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 39
CHART 13 GLOBAL HEPATITIS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 40
CHART 14 GLOBAL TUBERCULOSIS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 41
CHART 15 GLOBAL SEXUALLY TRANSMITTED DISEASE TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 42
CHART 16 GLOBAL HEALTHCARE-ASSOCIATED INFECTIONS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 43
CHART 17 GLOBAL RESPIRATORY INFECTIONS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 44
CHART 18 GLOBAL OTHERS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 45
CHART 19 GLOBAL PREGNANCY AND FERTILITY TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 46
CHART 20 GLOBAL HEMATOLOGY TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 47
CHART 21 GLOBAL CARDIOMETABOLIC MONITORING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 48
CHART 22 GLOBAL URINALYSIS TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 49
CHART 23 GLOBAL COAGULATION MONITORING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 51
CHART 24 GLOBAL TUMOUR OR CANCER MARKER TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 52
CHART 25 GLOBAL CHOLESTEROL TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 53
CHART 26 GLOBAL DRUGS OF ABUSE TESTING MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 54
CHART 27 GLOBAL OTHERS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 55
CHART 28 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY PRESCRIPTION MODE, 2018 V/S 2025 (%) 56
CHART 29 GLOBAL PRESCRIPTION-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 57
CHART 30 GLOBAL OTC-BASED POINT-OF-CARE DIAGNOSTICS MARKET REVENUE FORECAST, 2019–2025 ($MILLION) 59
CHART 31 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY END-USERS SEGMENTATION, 2018 (%) 60
CHART 32 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY GEOGRAPHICAL SEGMENTATION, 2018 V/S 2025 (%) 63
CHART 33 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN NORTH AMERICA, 2019–2025 ($MILLION) 64
CHART 34 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN EUROPE, 2019–2025 ($MILLION) 66
CHART 35 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN UNITED KINGDOM, 2019–2025 ($MILLION) 68
CHART 36 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN GERMANY, 2019–2025 ($MILLION) 69
CHART 37 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN FRANCE, 2019–2025 ($MILLION) 70
CHART 38 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN SPAIN, 2019–2025 ($MILLION) 71
CHART 39 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN ITALY, 2019–2025 ($MILLION) 72
CHART 40 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN OTHER EUROPEAN COUNTRIES, 2019–2025 ($MILLION) 72
CHART 41 POINT-OF-CARE DIAGNOSTICS REVENUE IN ASIA-PACIFIC, 2019–2025 ($MILLION) 73
CHART 42 POINT-OF-CARE DIAGNOSTICS MARKET REVENUE IN REST OF THE WORLD, 2019–2025 ($MILLION) 76
CHART 43 ABBOTT LABORATORIES.: OVERVIEW SNAPSHOT 86
CHART 44 ABBOTT LABORATORIES.: BUSINESS UNITS 87
CHART 45 ABBOTT LABORATORIES: GEOGRAPHIC PRESENCE 88
CHART 46 ABBOTT LABORATORIES.: SWOT ANALYSIS 88
CHART 51 JOHNSON & JOHNSON: OVERVIEW SNAPSHOT 100
CHART 52 JOHNSON & JOHNSON: BUSINESS UNITS 102
CHART 53 JOHNSON & JOHNSON: GEOGRAPHIC REVENUE 103
CHART 54 JOHNSON & JOHNSON: SWOT ANALYSIS 104
CHART 55 DANAHER CORPORATION: OVERVIEW SNAPSHOT 111
CHART 56 DANAHER CORPORATION: BUSINESS UNITS 112
CHART 57 DANAHER CORPORATION: GEOGRAPHIC PRESENCE 113
CHART 58 DANAHER CORPORATION: SWOT ANALYSIS 114
CHART 59 SIEMENS HEALTHINEERS, INC.: OVERVIEW SNAPSHOT 120
CHART 60 SIEMENS HEALTHINEERS, INC.: BUSINESS UNITS 121
CHART 61 SIEMENS HEALTHINEERS: GEOGRAPHIC PRESENCE 121
CHART 62 SIEMENS HEALTHINEERS INC.: SWOT ANALYSIS 122
 

 

List of Tables


Tables

TABLE 1 FUNDING SCENARIO 19
TABLE 2 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCTS, 2018–2025 ($MILLION) 33
TABLE 3 GLOBAL INFECTIOUS DISEASE POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2018–2025 ($MILLION) 36
TABLE 4 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET, BY PRESCRIPTION MODE, 2018–2025 ($MILLION) 57
TABLE 5 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET REVENUE BY REGIONS, 2018–2025 ($MILLION) 64
TABLE 6 EUROPEAN POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY, 2018–2025 ($MILLION) 67
TABLE 7 GLOBAL POINT-OF-CARE DIAGNOSTICS MARKET BY VENDOR RANKING, 2018 79
TABLE 8 OTHER PROMINENT VENDORS OF POINT-OF-CARE DIAGNOSTICS MARKET 79
TABLE 9 ABBOTT LABORATORIES: PRODUCT OFFERINGS 81
TABLE 10 ABBOTT LABORATORIES: RECENT DEVELOPMENTS 82
TABLE 11 F. HOFFMANN-LA ROCHE: PRODUCT OFFERINGS 90
TABLE 12 F. HOFFMANN-LA ROCHE: RECENT DEVELOPMENTS 91
TABLE 13 JOHNSON & JOHNSON: PRODUCT OFFERINGS 98
TABLE 14 JOHNSON & JOHNSON: RECENT DEVELOPMENTS 98
TABLE 15 DANAHER CORPORATION: PRODUCT OFFERINGS 106
TABLE 16 DANAHER CORPORATION: RECENT DEVELOPMENTS 109
TABLE 17 SIEMENS HEALTHINEERS INC.: PRODUCT OFFERINGS 116
TABLE 18 SIEMENS HEALTHINEERS INC.: RECENT DEVELOPMENTS 117
TABLE 19 TRINITY BIOTECH PLC: SNAPSHOT 124
TABLE 20 TRINITY BIOTECH PLC: RECENT DEVELOPMENTS 125
TABLE 21 QIAGEN N.V.: SNAPSHOT 125
TABLE 22 QIAGEN N.V.: RECENT DEVELOPMENTS 126
TABLE 23 BIOMERIEUX S.A.: SNAPSHOT 131
TABLE 24 BIOMERIEUX S.A.: RECENT DEVELOPMENTS 132
TABLE 25 ORASURE TECHNOLOGIES: SNAPSHOT 133
TABLE 26 ORASURES TECHNOLOGIES: RECENT DEVELOPMENTS 134
TABLE 27 INSTRUMENTATION LABORATORY: SNAPSHOT 134
TABLE 28 INSTRUMENTATION LABORATORY: RECENT DEVELOPMENTS 135
TABLE 29 BECTON DICKINSON AND COMPANY: SNAPSHOT 136
TABLE 30 BECTON DICKINSON AND COMPANY: RECENT DEVELOPMENTS 137
TABLE 31 NOVA BIOMEDICAL: SNAPSHOT 139
TABLE 32 NOVA BIOMEDICAL: RECENT DEVELOPMENTS 139

?